Parthenon Capital in its investment in Medical Review Institute of America (MRIoA), a provider of outsourced utilization management and clinical review solutions to payers.
Berkshire Partners in its acquisition of Medalogix.
General Catalyst and Health Assurance Transformation, LLC (HATCo) on the proposed combination of Summa Health with HATCo.
Vyaire Medical, Inc. and its 27 debtor affiliates in the completion of the sales of substantially all assets related to its two business units under Section 363 of the U.S. Bankruptcy Code and confirmation of its Chapter 11 plan.
GTCR, alongside Recognize, in the $632.4 million acquisition of TRANZACT from WTW (NASDAQ: WTW).
Altaris in its $540 million acquisition of Sharecare (NASDAQ: SHCR), a provider of a digital healthcare platform.
Owens & Minor (NYSE: OMI) in its pending $1.4 billion acquisition of Rotech Healthcare Holdings.
Invitae Corporation and certain of its affiliates in their prearranged Chapter 11 cases in the U.S. Bankruptcy Court for the District of New Jersey. Invitae is headquartered in San Francisco, California and is a leader in the genetic testing field. Prior to commencing Chapter 11, Invitae secured support to implement a go-forward sale process by signing a transaction support agreement with a significant majority of its secured noteholders. Invitae is a publicly traded company and listed approximately $1.5 billion in funded debt obligations as of the petition date.
